Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis
- PMID: 22926344
- DOI: 10.1038/nrrheum.2012.145
Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis
Comment on
-
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.N Engl J Med. 2012 Aug 9;367(6):495-507. doi: 10.1056/NEJMoa1109071. N Engl J Med. 2012. PMID: 22873530 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
